Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Un Pae

Showing results (231-240 of 387) with videos related to

Pageof 39
Sort By:
Expert Opinion on Investigational Drugs|April 27, 2017
Investigational dopamine antagonists for the treatment of schizophreniaSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
International Journal of Psychiatry in Clinical Practice|November 30, 2011
DAOA variants and schizophrenia: influence on diagnosis and treatment outcomesAlberto Chiesa, Chi-Un Pae, Stefano Porcelli, et al.
Expert Review of Neurotherapeutics|October 22, 2011
Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatmentMin-Hyeon Park, Changsu Han, Chi-Un Pae, et al.
Chonnam Medical Journal|October 1, 2016
Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An UpdateSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Psychiatry Research|March 15, 2011
Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophreniaAlessandro Serretti, Alberto Chiesa, Stefano Porcelli, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 25, 2021
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of SchizophreniaJung-Jin Kim, Chi-Un Pae, Changsu Han, et al.
Psychiatry and Clinical Neurosciences|January 10, 2003
Tumor necrosis factor-beta gene polymorphism may not be associated with major depressive disorder in the Korean populationTae-Youn Jun, Chi-Un Pae, Jeong-Ho Chae, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 2, 2019
The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective StudyChangsu Han, Sheng-Min Wang, Won-Myong Bahk, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2005
Long-term treatment of adjunctive quetiapine for bipolar maniaChi-Un Pae, Tae-Suk Kim, Jung-Jin Kim, et al.
Expert Review of Neurotherapeutics|October 9, 2012
Can botulinum toxin improve mood in depressed patients?Changsu Han, Geun-Young Park, Sheng-Min Wang, et al.
Pageof 39

Showing results (231-240 of 387) with videos related to

Sort By:
Pageof 39
Expert Opinion on Investigational Drugs|April 27, 2017
Investigational dopamine antagonists for the treatment of schizophreniaSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
International Journal of Psychiatry in Clinical Practice|November 30, 2011
DAOA variants and schizophrenia: influence on diagnosis and treatment outcomesAlberto Chiesa, Chi-Un Pae, Stefano Porcelli, et al.
Expert Review of Neurotherapeutics|October 22, 2011
Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatmentMin-Hyeon Park, Changsu Han, Chi-Un Pae, et al.
Chonnam Medical Journal|October 1, 2016
Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An UpdateSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Psychiatry Research|March 15, 2011
Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophreniaAlessandro Serretti, Alberto Chiesa, Stefano Porcelli, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 25, 2021
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of SchizophreniaJung-Jin Kim, Chi-Un Pae, Changsu Han, et al.
Psychiatry and Clinical Neurosciences|January 10, 2003
Tumor necrosis factor-beta gene polymorphism may not be associated with major depressive disorder in the Korean populationTae-Youn Jun, Chi-Un Pae, Jeong-Ho Chae, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 2, 2019
The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective StudyChangsu Han, Sheng-Min Wang, Won-Myong Bahk, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2005
Long-term treatment of adjunctive quetiapine for bipolar maniaChi-Un Pae, Tae-Suk Kim, Jung-Jin Kim, et al.
Expert Review of Neurotherapeutics|October 9, 2012
Can botulinum toxin improve mood in depressed patients?Changsu Han, Geun-Young Park, Sheng-Min Wang, et al.
Pageof 39